Natco Pharma gets USFDA nod for generic cancer drug, shares rise 4% intra-day
Natco Pharma gets USFDA nod for generic cancer drug, shares rise 4% intra-day. A business report from Daily Junction.
Marcus Vale
381 reading now
#Usfda
Stories tagged “Usfda”.
1 story